Skip to main content
Log in

Protective potential of Coriandrum sativum seed extract on E. coli induced peritonitis and bacteraemia in mice

  • Short Communications
  • Published:
Oriental Pharmacy and Experimental Medicine Aims and scope Submit manuscript

Abstract

Peritonitis is an inflammatory condition of peritoneal cavity. Escherichia coli is one of the causative microorganism reported to be involved in the several etiologies associated with peritoneal infection. Many antimicrobial agents are available; however, increased incidence of microbial resistance is an important concern for medical practitioner. Medicinal plants were used since ancient time for treatment of many infectious diseases, but still the potential of these plant resources is not well explored. Present study was designed to investigate protective potential of Coriandrum sativum seed extract on E. coli induced peritonitis and bacteraemia, when used alone or in combination with Levofloxacin. Different extracts were prepared by successive solvent extraction utilizing solvents of variable polarity viz. petroleum ether, ethyl acetate, chloroform and methanol (70%). These extracts were assessed for antimicrobial potential utilizing in-vitro well diffusion assay and MIC determination with E. coli, Staphylococcus aureus, Pseudomonas aeruginosa and Bacillus cereus. Being most potent among other extracts in in-vitro assays, methanolic extract was tested in an invivo model of E. coli induced peritonitis with immune-compromised mice at the dose of 400 mg/kg/day alone and in combination with Levofloxacin (20 mg/kg). Methanolic extract of Coriandrum sativum seeds exhibited potent protective potential against E. coli induced peritonitis and bacteraemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  • Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GFM (2017) Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 4:CD004679. https://doi.org/10.1002/14651858.CD004679.pub3

    PubMed  Google Scholar 

  • Chauhan PS, Satti NK, Suri KA, Amina M, Bani S (2010) Stimulatory effects of Cuminum Cyminum and flavonoid glycoside on cyclosporine-a and restraint stress induced immune-suppression in Swiss albino mice. Chem-biol int 185(1):66–72

    Article  CAS  Google Scholar 

  • Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB (2013) Recent advances in understanding enteric pathogenic Escherichia Coli. Clil micro rev 26(4):822–880

    Article  CAS  Google Scholar 

  • Delahaye CH et al (2009) Antibacterial and antifungal analysis of crude extracts from the leaves of Callistemon Viminalis. Journal of Medical and biological sciences 3(1):1–7

    Google Scholar 

  • Dunn CW, Horton JW, Walker PB (1989) Additive effect of an immunomodulator and broad-spectrum antibiotic in fecal peritonitis. Am J Surg 157(6):548–551

    Article  CAS  PubMed  Google Scholar 

  • Esposito S, Noviello S, Leone S, Ianniello F, Ascione T, Gaeta GB (2006) Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study. J Chemother 18(1):33–37

    Article  CAS  PubMed  Google Scholar 

  • Frazier WJ, Wang X, Wancket LM, Li XA, Meng X, Nelin LD, Liu Y (2009) Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice. The J Immuno 183(11):7411–7419

    Article  CAS  Google Scholar 

  • García-Laorden MI, Stroo I, Terpstra S, Florquin S, Medema JP, de Vos AF, Van der Poll T (2017) Expression and function of Granzymes a and B in Escherichia Coli peritonitis and sepsis. Medi Inflam. https://doi.org/10.1155/2017/4137563

  • Guo B, Abdelraouf K, Ledesma KR, Chang KT, Nikolaou M, Tam VH (2011) Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model. Antimicro agents chemother 55(10):4601–4605

    Article  CAS  Google Scholar 

  • Hecker A, Uhle F, Schwandner T, Padberg W, Weigand MA (2014) Diagnostics, therapy and outcome prediction in abdominal sepsis: current standards and future perspectives. Langenbeck's Arch Surg 399(1):11–22

    Article  CAS  Google Scholar 

  • Inoue Y, Grant JP, Snyder PJ (1993) Effect of glutamine-supplemented intravenous nutrition on survival after Escherichia Coli-induced peritonitis. J Parent Ent Nutri 17(1):41–46

    Article  CAS  Google Scholar 

  • Isogai E, Isogai H, Hayashi S, Kubota T, Kimura K, Fujii N, Ohtani T, Sato K (2000) Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia Coli O157 infection. Microbiol immuno 44(2):89–95

    Article  CAS  Google Scholar 

  • Johri RK (2011) Cuminum cyminum and Carum carvi: An update. Pharmacog rev 5(9):63

    Article  CAS  Google Scholar 

  • Knapp S, de Vos AF, Florquin S, Golenbock DT, Van der Poll T (2003) Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia Coli peritonitis in mice. Infect Immun 71(12):6747–6753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kokate CK et al (2006) A text book of practical pharmacognosy, 23rd edn. Nirali prakashan, Pune, pp 493–497

    Google Scholar 

  • Lo Cantore P, Iacobellis NS, De Marco A, Capasso F, Senatore F (2004) Antibacterial activity of Coriandrum Sativum L. and Foeniculum Vulgare Miller Var. Vulgare (miller) essential oils. J Agric Food Chem 52(26):7862–7866

    Article  CAS  PubMed  Google Scholar 

  • Mueller JH, Hinton J (1941) A protein-free medium for primary isolation of the gonococcus and meningococcus. Proc Soc Exp Biol Med 48(1):330–333

    Article  CAS  Google Scholar 

  • Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken HR (1995) Manual of clinical microbiology, 6th edn. ASM Press, Washington DC, pp 15–18

    Google Scholar 

  • OECD 423, class, A. O. T. A. T. (2001). OECD Guideline for testing of chemicals

  • Pavlidis TE (2003) Cellular changes in association with defense mechanisms in intra-abdominal sepsis. Minerva Chir 58(6):777–781

    CAS  PubMed  Google Scholar 

  • Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, Patry L, A. (2014) Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infect Dis 14(1):287. https://doi.org/10.1186/1471-2334-14-287

    Article  PubMed  PubMed Central  Google Scholar 

  • Riché F, Gayat E, Collet C, Matéo J, Laisné MJ, Launay JM, Cholley BP (2013) Local and systemic innate immune response to secondary human peritonitis. Crit Care 17(5):R201. https://doi.org/10.1186/cc12895

    Article  PubMed  PubMed Central  Google Scholar 

  • Salem ML (2005) Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 5(13–14):1749–1770

    Article  CAS  PubMed  Google Scholar 

  • Sheikhian A, Rezapour S, Shirzad H (2016) The most important Iranian medicinal plants with immunomodulatory property according to traditional medicine and modern research findings. J Chem Pharm Sci 9(4):3423–3426

    Google Scholar 

  • Trease GE, Evans WC (1989) Pharmacognosy. Bailliere Tindall, London, pp 45–50

    Google Scholar 

  • Van Till JO, Van Veen SQ, Van Ruler O, Lamme B, Gouma DJ, Boermeester MA (2007) The innate immune response to secondary peritonitis. Shock 28(5):504–517

    PubMed  Google Scholar 

  • Vikrant S, Guleria RC, Kanga A, Verma BS, Singh D, Dheer SK (2013) Microbiological aspects of peritonitis in patients on continuous ambulatory peritoneal dialysis. Indian J Nephrol 23(1):12–17. https://doi.org/10.4103/0971-4065.107188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Waymack JP, Miskell P, Gonce SJ, Alexander JW (1984) Immunomodulators in the treatment of peritonitis in burned and malnourished animals. Surgery 96(2):308–314

    CAS  PubMed  Google Scholar 

  • Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214

    Article  CAS  PubMed  Google Scholar 

  • Williams DL, Browder IW, Di Luzio NR (1983) Immunotherapeutic modification of Escherichia Coli-induced experimental peritonitis and bacteremia by glucan. Surgery 93(3):448–454

    CAS  PubMed  Google Scholar 

  • Williams DL, Sherwood ER, Browder IW, McNamee RB, Jones EL, Rakinic J, Di Luzio NR (1988) Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis. J Surg Res 44(1):54–61

    Article  CAS  PubMed  Google Scholar 

  • Xin-Zhi C, Jian-Ming Y, Shen-Xin L, You-Liang Z (2012) Antimicrobial activity of the extracts from Coriandrum Sativum. Int J Food Nutri Safety 1(2):54–59

    Google Scholar 

Download references

Acknowledgements

Authors acknowledge Prof. S. B. Kasture for his valuable suggestions in preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neha Jain.

Ethics declarations

Ethical Statement

All animal experiments were approved by Institutional Animal Ethics Committee (IAEC) of PBRI, Bhopal (CPCSEA Reg No. - 1283/PO/c/09/CPCSEA).

Conflict of Interest

The study was self-financed and authors declares no conflict with any individual or organisation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, N., Dwivedi, J., Kasture, V.S. et al. Protective potential of Coriandrum sativum seed extract on E. coli induced peritonitis and bacteraemia in mice. Orient Pharm Exp Med 17, 409–415 (2017). https://doi.org/10.1007/s13596-017-0284-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13596-017-0284-8

Keywords

Navigation